How Old is Too Old? Closure of Patent Foramen Ovale in Older Patients
Percutaneous closure of a patent foramen ovale (PFO) reduces the risk of recurrent cryptogenic stroke specifically in younger patients. The three randomized controlled trials that led to the widespread adoption of PFO closure excluded patients over the age of 60 years. Older patients frequently have...
Saved in:
Main Authors: | Carlos Vazquez-Sosa, Stacey D Clegg, James C Blankenship |
---|---|
Format: | article |
Language: | EN |
Published: |
Radcliffe Medical Media
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b323103fa1b54065adbaba5e98ebeea0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patent Foramen Ovale Closure in 2019
by: Joel P Giblett, et al.
Published: (2019) -
Patent Foramen Ovale Closure: State of the Art
by: Joel P Giblett, et al.
Published: (2020) -
Percutaneous closure of the patent foramen ovale: A cardiological perspective
by: S.C. Brown
Published: (2017) -
Long-term follow-up outcomes in a real-world study cohort after percutaneous patent foramen ovale closure
by: Ahmet Hakan Ateş, et al.
Published: (2021) -
Atrial fibrillation screening on systematic ambulatory electrocardiogram monitoring after percutaneous patent foramen ovale closure: A prospective study
by: Florence Leclercq, et al.
Published: (2021)